W Vos

1.9k total citations
48 papers, 1.4k citations indexed

About

W Vos is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, W Vos has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pathology and Forensic Medicine, 20 papers in Oncology and 15 papers in Immunology. Recurrent topics in W Vos's work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (11 papers) and Immune Cell Function and Interaction (10 papers). W Vos is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (11 papers) and Immune Cell Function and Interaction (10 papers). W Vos collaborates with scholars based in Netherlands, Germany and Romania. W Vos's co-authors include C J Meijer, A Horstman, Danny F. Dukers, Paul van der Valk, G.J. Ossenkoppele, Natasha Jiwa, Chris J.L.M. Meijer, H. Mullink, J. M. M. Walboomers and Joost J. Oudejans and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

W Vos

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Vos Netherlands 23 753 720 416 330 178 48 1.4k
Karen P. Mann United States 21 752 1.0× 656 0.9× 318 0.8× 233 0.7× 197 1.1× 46 1.5k
Hirokazu Nakamine Japan 21 718 1.0× 921 1.3× 360 0.9× 227 0.7× 318 1.8× 101 1.5k
Carmen Bellas Spain 22 647 0.9× 724 1.0× 933 2.2× 318 1.0× 250 1.4× 59 1.9k
Howard Ratech United States 21 701 0.9× 566 0.8× 716 1.7× 441 1.3× 188 1.1× 74 2.0k
H. J. Ree United States 24 855 1.1× 1.1k 1.5× 603 1.4× 301 0.9× 222 1.2× 64 1.8k
Yoshihiro Yakushijin Japan 23 766 1.0× 421 0.6× 493 1.2× 363 1.1× 268 1.5× 87 1.6k
Zhong-Jun Xia China 20 1.0k 1.4× 760 1.1× 544 1.3× 235 0.7× 139 0.8× 50 1.5k
Dai Maruyama Japan 24 816 1.1× 1.0k 1.4× 299 0.7× 214 0.6× 329 1.8× 164 1.6k
Momoko Nishikori Japan 20 906 1.2× 735 1.0× 566 1.4× 335 1.0× 311 1.7× 99 1.7k
WC Chan United States 19 718 1.0× 959 1.3× 707 1.7× 219 0.7× 405 2.3× 26 1.6k

Countries citing papers authored by W Vos

Since Specialization
Citations

This map shows the geographic impact of W Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Vos more than expected).

Fields of papers citing papers by W Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Vos. The network helps show where W Vos may publish in the future.

Co-authorship network of co-authors of W Vos

This figure shows the co-authorship network connecting the top 25 collaborators of W Vos. A scholar is included among the top collaborators of W Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Vos. W Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matzaraki, Vasiliki, Marc J. T. Blaauw, W Vos, et al.. (2025). Plasma Proteomic Signature as a Predictor of Age Advancement in People Living With HIV. Aging Cell. 24(5). e14468–e14468.
2.
Santos, Jéssica Cristina dos, Bram van Cranenbroek, W Vos, et al.. (2025). Circulating immune landscape and immune signatures in spontaneous HIV controllers. Frontiers in Immunology. 16. 1642482–1642482. 1 indexed citations
3.
Jiang, Xun, Manoj Kumar Gupta, Jéssica Cristina dos Santos, et al.. (2024). Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands. Frontiers in Immunology. 15. 1459593–1459593.
5.
Mast, Quirijn de, Marc J. T. Blaauw, W Vos, et al.. (2024). Plasma proteomic signatures of liver steatosis and fibrosis in people living with HIV: a cross-sectional study. EBioMedicine. 109. 105407–105407. 3 indexed citations
6.
Vos, W, Marc J. T. Blaauw, Vasiliki Matzaraki, et al.. (2024). HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity. Frontiers in Immunology. 15. 1350065–1350065. 7 indexed citations
7.
Zhang, Yue, W Vos, Lisa Van de Wijer, et al.. (2023). High-throughput proteomic analysis reveals systemic dysregulation in virally suppressed people living with HIV. JCI Insight. 8(11). 5 indexed citations
8.
Blaauw, Marc J. T., Marvin A. H. Berrevoets, W Vos, et al.. (2023). Traditional Cardiovascular Risk Factors Are Stronger Related to Carotid Intima‐Media Thickness Than to Presence of Carotid Plaques in People Living With HIV. Journal of the American Heart Association. 12(20). e030606–e030606. 8 indexed citations
9.
Radonic, Teodora, et al.. (2020). Influence of preanalytical variables on performance of delta-like protein 3 (DLL3) predictive immunohistochemistry. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(2). 293–300. 1 indexed citations
10.
Galen, Joost C. van, Jettie J.F. Muris, W Vos, et al.. (2008). Expression of TNF‐receptor associated factor 2 correlates with poor progression‐free survival time in ABC‐like primary nodal diffuse large B‐cell lymphomas. Histopathology. 52(5). 578–584. 6 indexed citations
12.
Muris, Jettie J.F., C J Meijer, Saskia A.G.M. Cillessen, et al.. (2003). Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia. 18(3). 589–596. 77 indexed citations
14.
Vermeer, Maarten H., Danny F. Dukers, Rosita L. ten Berge, et al.. (2002). Differential Expression of Thymus and Activation Regulated Chemokine and Its Receptor CCR4 in Nodal and Cutaneous Anaplastic Large-Cell Lymphomas and Hodgkin’s Disease. Modern Pathology. 15(8). 838–844. 32 indexed citations
15.
Jaspars, Lies H., W Vos, Gabriela Aust, René A. W. van Lier, & Jörg Hamann. (2001). Tissue distribution of the human CD97 EGF‐TM7 receptor. Tissue Antigens. 57(4). 325–331. 68 indexed citations
16.
Bai, M, Natasha Jiwa, A Horstman, et al.. (1994). Decreased expression of cellular markers in Epstein‐Barr virus‐positive Hodgkin's disease. The Journal of Pathology. 174(1). 49–55. 29 indexed citations
17.
Jiwa, Natasha, Panagiotis Kanavaros, Peter C. de Bruin, et al.. (1993). Presence of Epstein‐Barr virus harbouring small and intermediate‐sized cells in Hodgkin'S disease. Is there a relationship with Reed‐Sternberg cells?. The Journal of Pathology. 170(2). 129–136. 37 indexed citations
18.
19.
Blomjous, C.E.M., Erik Thunnissen, W Vos, H. J. de Voogt, & Chris J.L.M. Meijer. (1988). Small cell neuroendocrine carcinoma of the urinary bladder. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 413(6). 505–512. 22 indexed citations
20.
Rijlaarsdam, J. U., D. P. Bruynzeel, W Vos, C J Meijer, & Rein Willemze. (1988). Immunohistochemical Studies of Lymphadenosis Benigna Cutis Occurring in a Tattoo. American Journal of Dermatopathology. 10(6). 518–523. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026